Croda announces director retirement

5 March 2025

Croda International Plc announces that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical.

Danuta Gray, Chair of Croda International Plc, commented:

"Julie Kim has made an excellent contribution and we wish her every success for the future in the next stage of her executive career at Takeda Pharmaceuticals.”

ENDS

For enquiries contact:
Investors: David Bishop, Croda +44 7823 874428
Media: Charlie Armistead, FTI Consulting +44 7703 330269

About Croda
Croda is a specialty chemicals company that creates high performance ingredients and solutions principally for Consumer Care and Life Sciences markets. Established 100 years ago in 1925 and headquartered in the UK, Croda is a FTSE 100 company with over 5,800 employees across 92 locations in 39 countries. Revenues in 2023 were £1.69bn.

As the name behind some of the world’s most successful brands, we combine our knowledge, passion and entrepreneurial spirit to develop and supply innovative ingredients relied on by industries and consumers around the world. Our smart science is found in products that touch our lives every day from sun protection to life-saving pharmaceuticals and formulations that enhance crop yields.

With a shared Purpose to use Smart science to improve lives™, and with around two thirds of its organic raw materials already from bio-based sources, Croda has committed to be the most sustainable supplier of innovative ingredients, becoming Climate, Land and People Positive by 2030 while providing solutions to some of the world’s biggest challenges.